Autologous transfusion - A reasonable measure under the principles of health economics?

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 38, Issue 1, 2003, Pages 54-58

  Sonnenberg, F A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BACTERIAL INFECTION; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; EXPERIMENTAL MODEL; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PROGNOSIS; RISK FACTOR; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; VIRUS TRANSMISSION;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; HEPATITIS, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; RISK ASSESSMENT; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 0037252666     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-36566     Document Type: Conference Paper

References (10)

1. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333(26): 721-1725
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334(26): 685-1690
3. Healy JC, Frankforter SA, Graves BK, Reddy RL, Beck JR. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis. Arch Pathol Lab Med 1994; 118(4): 465-470
4. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332(11): 719-724
5. Sonnenberg FA, Gregory P, Yomtovian R, Russell LB, Tierney W, Kosmin M, et al. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 1999; 39(8): 808-817
6. Sonnenberg FA. A Health Economic Analysis of Autologous Transfusion. Infusion Therapy and Transufsion Medicine 2002
7. Busch OR, Hop WC, Hoynck vanPapendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328(19): 1372-1376
8. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342(8883): 1328-1333
9. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39(7): 694-700
10. Wong JB, Koff RS, Tine F, Pauker SG. Cost-effectiveness of interferonalpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 1995; 122(9): 664-675